Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Wenwei Hua,
Cen Zhanga,
Rui Wua,
Yvonne Suna,
Arnold Levinea,b,1, and
Zhaohui Fenga,1
aCancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08903; and b Institute for Advanced Study, Princeton, NJ 08540
Contributed by Arnold J. Levine, January 28, 2010 (sent for review November 30, 2009)
Abstract:
Whereas cell cycle arrest, apoptosis, and senescence are traditionallythought of as the major functions of the tumor suppressor p53,recent studies revealed two unique functions for this protein:p53 regulates cellular energy metabolism and antioxidant defensemechanisms. Here, we identify glutaminase 2 (GLS2) as a previouslyuncharacterized p53 target gene to mediate these two functionsof the p53 protein. GLS2 encodes a mitochondrial glutaminasecatalyzing the hydrolysis of glutamine to glutamate. p53 increasesthe GLS2 expression under both nonstressed and stressed conditions.GLS2 regulates cellular energy metabolism by increasing productionof glutamate and -ketoglutarate, which in turn results in enhancedmitochondrial respiration and ATP generation. Furthermore, GLS2regulates antioxidant defense function in cells by increasingreduced glutathione (GSH) levels and decreasing ROS levels,which in turn protects cells from oxidative stress (e.g., H2O2)-inducedapoptosis. Consistent with these functions of GLS2, the activationof p53 increases the levels of glutamate and -ketoglutarate,mitochondrial respiration rate, and GSH levels and decreasesreactive oxygen species (ROS) levels in cells. Furthermore,GLS2 expression is lost or greatly decreased in hepatocellularcarcinomas and the overexpression of GLS2 greatly reduced tumorcell colony formation. These results demonstrated that as aunique p53 target gene, GLS2 is a mediator of p53s rolein energy metabolism and antioxidant defense, which can contributeto its role in tumor suppression.
Key Words: reactive oxygen species oxidative phosphorylation
Author contributions: W.H., A.L., and Z.F. designed research;W.H., C.Z., R.W., Y.S., and Z.F. performed research; W.H., A.L.,and Z.F. analyzed data; and W.H., A.L., and Z.F. wrote the paper.
J. Liu and Z. Feng (2012)
Acta Biochim Biophys Sin
44, 629-631
|Full Text »|PDF »
Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.
K. Thangavelu, C. Q. Pan, T. Karlberg, G. Balaji, M. Uttamchandani, V. Suresh, H. Schuler, B. C. Low, and J. Sivaraman (2012)
PNAS
109, 7705-7710
|Abstract »|Full Text »|PDF »
The Fundamental Role of the p53 Pathway in Tumor Metabolism and Its Implication in Tumor Therapy.
L. Shen, X. Sun, Z. Fu, G. Yang, J. Li, and L. Yao (2012)
Clin. Cancer Res.
18, 1561-1567
|Abstract »|Full Text »|PDF »
Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.
A. Cassago, A. P. S. Ferreira, I. M. Ferreira, C. Fornezari, E. R. M. Gomes, K. S. Greene, H. M. Pereira, R. C. Garratt, S. M. G. Dias, and A. L. B. Ambrosio (2012)
PNAS
109, 1092-1097
|Abstract »|Full Text »|PDF »
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2.
Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses.
D. Anastasiou, G. Poulogiannis, J. M. Asara, M. B. Boxer, J.-k. Jiang, M. Shen, G. Bellinger, A. T. Sasaki, J. W. Locasale, D. S. Auld, et al. (2011)
Science
334, 1278-1283
|Abstract »|Full Text »|PDF »
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.
C. Zhang, M. Lin, R. Wu, X. Wang, B. Yang, A. J. Levine, W. Hu, and Z. Feng (2011)
PNAS
108, 16259-16264
|Abstract »|Full Text »|PDF »
Role of Glutamine in Cancer: Therapeutic and Imaging Implications.
K. N. Rajagopalan and R. J. DeBerardinis (2011)
J. Nucl. Med.
52, 1005-1008
|Abstract »|Full Text »|PDF »
Serine/Threonine Kinase 17A Is a Novel p53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells.
P. Mao, M. P. Hever, L. M. Niemaszyk, J. M. Haghkerdar, E. G. Yanco, D. Desai, M. J. Beyrouthy, J. S. Kerley-Hamilton, S. J. Freemantle, and M. J. Spinella (2011)
J. Biol. Chem.
286, 19381-19391
|Abstract »|Full Text »|PDF »